Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium-Competitive Acid Blocker vs Proton Pump Inhibitor for Gastroprotection in High Bleeding Risk Patients on Antithrombotic Therapy
KCT0008146Phase 4Recruiting
- Sponsor
- Cardiovascular Research Foundation
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in cardiac morbidity, gastrointestinal bleeding, sponsored by Cardiovascular Research Foundation. Started Oct 2023; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
cardiac morbiditygastrointestinal bleeding
Beyond the preview
Go deeper on KCT0008146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008146.